Revvity Signals

AI can reduce admin burden and speed insights in clinical development, but it can’t replace human expertise, ethics, or regulatory accountability. Key takeaways from a Panelle + Revvity Signals roundtable with leaders across data, oncology, and more: ms.spr.ly/6014QUAUA

Trustworthy AI is becoming non negotiable in #clinicaltrials. In this SelectScience article, Dr. Simone Sharma, @RevvitySignals, shares why regulated environments demand more than high performance algorithms. 🔗 eu1.hubs.ly/H0sv79L0 #clinicaldatamanagement #clinicaldata

What makes #AI trustworthy in clinical trials? #RevvitySignals' Simone Sharma shares why reliability, and avoiding the pitfalls of general-purpose AI—matters for clinical development teams in this @SelectScience interview.: ms.spr.ly/6018QcMrp

NEWS: Revvity has completed the acquisition of @ACDLabs. Together, we’re strengthening end-to-end scientific workflows, from discovery to manufacturing, helping teams turn complex data into faster, more confident decisions. Learn more: ms.spr.ly/6011QejkR

Lab of the Future Boston is underway! 📍 Visit Booth 27 to meet the #RevvitySignals team. ➡️ Catch our own Joshua Bond with Eli Lilly and Company at 4:30 p.m., Grand Ballroom (Sheraton). We hope to connect and see you there!

Andrew Anderson, Senior Director, Product Portfolio at @RevvitySignals writes in @ContractLab on the AI-enabled DMTA cycle and the role of AI in ensuring continuity between each stage. Read more: #AI

Paper logs and disconnected spreadsheets make it easy for discrepancies in data to go unnoticed for months. Mobile lab inventory management systems can help teams cut annual inventory time by up to 97%. See how in our latest blog: ms.spr.ly/6010QnZ2M

#AI is changing clinical data review. Join our Signals Clinical Connect to see how the Custom Listing Generator in Signals Clinical™ helps teams create analysis-ready listings with natural language, no programming required. Save your spot here: ms.spr.ly/6014QPZXO

Research shouldn’t slow down because of compliance. Automated sign-offs, validation, and audit tracking help labs stay efficient and GxP-ready. Learn how Signals Notebook makes it possible in our new blog: ms.spr.ly/6014QzqmA

#SCOPE in Orlando is underway, and we’re here! 👋 Find the Revvity Signals team at Booth 126 to see how clinical teams can turn complex trial data into confident decisions. We'd love to connect! #ClinicalData #AI

Integrated workflows empower teams to capture knowledge, apply #AI to ingredient selection, visualize results in real time, and predict outcomes before experiments begin, all while accelerating innovation and reducing risk. 🔗New blog: ms.spr.ly/6015QJoex

Formulation work moves fast, but disconnected tools slow it down. Data gets lost, context disappears, and lessons learned are hard to reuse. A digital backbone brings formulations, experiments, and results together, helping you move from idea to insight: ms.spr.ly/6010Q8WlC

We're excited for our next Signals Connect! Chris Stumpf and the #RevvitySignals team will show how AI and ontology-driven data are transforming scientific workflows in Signals. 📅 Feb. 18. If this is up your alley, save your spot here: ms.spr.ly/6014QB2oY

Ever wonder why blue cheese smells…like that? For #NationalCheeseLoversDay, we turned to #ChemDraw to map the molecules behind the magic. Heptan-2-one and Nonan-2-one are the key ketones that give blue cheeses their unmistakable, sharp aroma. 🧀

2025 delivered real momentum in drug discovery, from CRISPR-based therapies to new chemistry frontiers. Our latest blog reflects on what defined the year for #RevvitySignals and what it means for the future of R&D: ms.spr.ly/6017tfppD

2026 could be a tipping point for life-science R&D. In a recent LabCompare feature, David Gosalvez explores how #AI-augmented molecular design is becoming the new standard for early discovery.: ms.spr.ly/6011t2ZSN

As Calyxia scaled, paper-based workflows couldn’t keep up. With Signals Notebook, the Paris-based chemistry startup unified #ELN, LIMS, and equipment management in one integrated system, powering continued digital transformation. Read the case study: ms.spr.ly/6012txLdI

What happens when #AI, collaboration, and connected science come together? At #RevvitySignals, we help researchers unlock insights from complex data to accelerate drug discovery and enable smarter decisions. Our latest blog: ms.spr.ly/6016tSjGC

As 2025 draws to a close, our President and CEO, Daria Thorp, reflects on an important milestone – the recent announcement of @RevvitySignals' definitive agreement to acquire ACD/Labs. Read the full story in our blog: buff.ly/qKKhi3j #acquisition #pharmaceutical

That gingerbread “zing” is chemistry at work. Gingerol (6-gingerol) transforms into zingerone or shogaol when heated, which is proof that molecular reactions make the season taste better. Happy holidays! ✨